Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aanjaay IndustriesBOM:524322 -2.75%31 Buyback Yield % is 0.00 as of Aug. 21, 2026. GuruFocus rates BOM:524322 with a GF Score™ of 31/100. The stock has 3 warning signs investors should review. Among 248 Drug Manufacturers companies, Aanjaay Industries ranks worse than 403225.4% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
Aanjaay Industries Buyback Yield % Historical Data
* Premium members only.
The historical data trend for Aanjaay Industries's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Aanjaay Industries's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aanjaay Industries Buyback Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Aanjaay Industries's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Aanjaay Industries's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aanjaay Industries (BOM:524322) has a Buyback Yield % of 0.00 as of Aug. 21, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Aanjaay Industries and its competitors. According to the industry distribution chart, Aanjaay Industries ranks #999999 out of 248 companies in the Drug Manufacturers industry.
Is Aanjaay Industries' Buyback Yield % too high?
Aanjaay Industries' current Buyback Yield % is 0.00. Based on the distribution chart, Aanjaay Industries ranks #999999 out of 248 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Aanjaay Industries has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Aanjaay Industries' Buyback Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Aanjaay Industries ranks #999999 out of 248 companies for Buyback Yield %. This places Aanjaay Industries in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Drug Manufacturers company?
A good Buyback Yield % depends on the Drug Manufacturers industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Aanjaay Industries and its competitors. Aanjaay Industries's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aanjaay Industries stock overvalued right now?
Aanjaay Industries (BOM:524322) has a current Buyback Yield % of 0.00. The current Buyback Yield % is 0.00. Aanjaay Industries' overall GF Score™ is 31/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Aanjaay Industries (BOM:524322), the current Buyback Yield % is 0.00 as of Aug. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kabra Drugs Ltd is an India-based drug manufacturing company. It is engaged in Permaculture manufacturing and trading in pharmaceutical products. Geographically, all the company operations are carried out in India. The company's drug manufacturing plant is located in Madhya Pradesh, India. Its products include Cardiovascular Drugs, Anti-Infective Drugs, Oncology Drugs, Gastrointestinal Drugs, and Hormonal Drugs.
31GF Score
Get the complete analysis for BOM:524322
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524322 has been successfully added to your 
